EBQ:PROPPR Trial: Difference between revisions

No edit summary
No edit summary
Line 70: Line 70:
*>3 U of pRBC given before randomization
*>3 U of pRBC given before randomization


==Interventions==  
==Interventions==
*Two cohorts received blood product ratios of 1:1:1 (n=338) vs 1:1:2 (n=342) during active resuscitation
 
==Outcomes==
==Outcomes==
   
   

Revision as of 12:57, 13 March 2015

incomplete Journal Club Article
Holcomb JB, Tilley BC, Baraniuk S, et al.. "Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma". JAMA. 2015. 313(5):471-482.
PubMed

Clinical Question

  • Compare 1:1:1 vs 1:1:2 in safety and efficacy in trauma rescus

Conclusion

  • No significant differences in mortality at 24 hours or at 30 days between two groups
  • More patients in the 1:1:1 group achieved hemostasis and fewer experienced death due to exsanguination by 24 hours (86% vs 78%; p=0.006)
  • Exsanguination in first 24 hours decreased in the 1:1:1 group (9.2% vs 14.6%; p=0.03)
  • No other safety differences were identified between the two groups

Major Points

  • This was a negative trial - the 1:1:1 was as safe as 1:1:2
  • They did not meet the 10% mortality advantage which the study was powered to but found 4.2% improvement in the 1:1:1 group at 24hr and 3.7% at 30d (not statistically significant)

Study Design

  • Randomized clinical trial

Population

  • 680 patients from of 12 participating level I trauma centers in North America

Patient Demographics

Characteristics 1:1:1 1:1:2
Age 34.5 (25-51) 34 (24-50)
Male 263 (77.8%) 283 (82.7%)
Race - White 210 (62.1%) 224 (65.5%)
Race - Black 94 (27.8%) 93 (27.2%)
Race - Other 35 (10.4%) 25 (7.3%)

Inclusion Criteria

  • Highest trauma level activation
  • ≥15 yo or weight ≥50 kg if age unknown
  • Received directly from the injury scene
  • Transfusion initiated with at least 1 U of blood component within the first hour of arrival
  • Predicted to receive a massive transfusion

Exclusion Criteria

  • Received a lifesaving intervention from OSH
  • Terminal injuries and expected to die within 1 hour of admission (eg, lethal traumatic brain injury)
  • Directly admitted from a correctional facility
  • Required a thoracotomy prior to randomization
  • <15 yo or <50 kg if age unknown
  • Pregnant
  • Burns >20% total BSA
  • Suspected inhalation injury
  • >5 mins of CPR
  • DNR
  • Enrolled in a concurrent, ongoing, interventional, randomized clinical trial
  • >3 U of pRBC given before randomization

Interventions

  • Two cohorts received blood product ratios of 1:1:1 (n=338) vs 1:1:2 (n=342) during active resuscitation

Outcomes

Primary Outcome

Secondary Outcomes

Subgroup analysis

Criticisms & Further Discussion

External Links

Podcast 144 – The PROPPR trial with John Holcomb

Funding

Sources